---
schema_version: "secwatch.filing_event.v1"
accession: "0000764180-24-000091"
form_type: "8-K"
ticker: "MO"
cik: "0000764180"
company_name: "ALTRIA GROUP, INC."
filed_at: "2024-07-31T23:59:59+00:00"
generated_at: "2026-05-31T14:38:02.094356+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Altria Q2 adjusted EPS flat at $1.31; narrows FY2024 guidance to $5.07-$5.15

## Summary
- Q2 adjusted diluted EPS $1.31 (flat YoY); reported EPS $2.21 (up 85.7% on IQOS gain).
- Q2 net revenue $6.2B (-4.6%); cigarette shipment volume down 13% (-11% adjusted); Marlboro retail share 42.0%.
- NJOY receives first FDA MGOs for menthol e-vapor; triggers $250M payment. NJOY retail share 5.5% (+1.3pp sequentially).
- FY2024 adjusted EPS guidance narrowed to $5.07-$5.15 (2.5%-4.0% growth); adjusted tax rate forecast 24.0%-25.0%.
- Skoal trademark impairment $354M non-cash; oral tobacco adjusted OCI +1.8%; on! volume up 37.3%.

## SEC filing metadata
- accession: 0000764180-24-000091
- form_type: 8-K
- ticker: MO
- cik: 0000764180
- company_name: ALTRIA GROUP, INC.
- filed_at: 2024-07-31T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/764180/000076418024000091/0000764180-24-000091-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/764180/000076418024000091/mo-20240731.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000764180-24-000091
- JSON: https://secwatch.observer/filing/0000764180-24-000091.json
- Plain text: https://secwatch.observer/filing/0000764180-24-000091.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.